论文部分内容阅读
随着转基因技术的不断发展,转基因食品在国际贸易中的比重越来越大。由于转基因食品本身安全性问题没有得到科学的确认和经济、文化等因素,由转基因食品引发的国际贸易争端也越来越多。世界贸易组织下的TBT协议、SPS协议、TRIPS协议对转基因食品贸易问题的规定与《生物多样性公约》《卡塔赫纳生物安全议定书》的规定有冲突的地方。中国作为转基因作物的种植大国,要积极加强自主知识产权的转基因生物的研究,积极参与世贸组织谈判,参与制定新的规则,大力发展我国的转基因产品出口贸易。
With the continuous development of transgenic technology, the proportion of genetically modified foods in international trade is growing. As the safety of genetically modified food itself has not been scientifically confirmed and economic, cultural and other factors, caused by genetically modified foods, more and more international trade disputes. The TBT agreement under the World Trade Organization, the SPS agreement and the provisions of the TRIPS Agreement on the issue of trade in genetically modified foods have conflicts with the provisions of the Cartagena Protocol on Biosafety to the Convention on Biological Diversity. China, as a large country that replaces biotech crops, should actively strengthen research on genetically modified organisms with independent intellectual property rights, actively participate in the WTO negotiations, participate in formulating new rules and vigorously develop China’s export trade of genetically modified products.